We are live on ! Find out more
SCI

S&CO Inc Portfolio holdings

AUM $1.61B
1-Year Est. Return 21.39%
This Fund
S&P 500
This Quarter Est. Return
+1.42%
1 Year Est. Return
+21.39%
3 Year Est. Return
+58.88%
5 Year Est. Return
+84.19%
10 Year Est. Return
+267.05%
AUM
$1.49B
AUM Growth
+$16.4M
Cap. Flow
+$17.1M
Cap. Flow %
1.15%
Top 10 Hldgs %
38.39%
Holding
221
New
11
Increased
53
Reduced
54
Closed
4

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$4.62M
2
UNH icon
UnitedHealth
UNH
+$3.99M
3
DBRG icon
DigitalBridge
DBRG
+$2.39M
4
MRK icon
Merck
MRK
+$2.17M
5
AMZN icon
Amazon
AMZN
+$2.01M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$6.62M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.27M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$3.11M
4
PPLI
People Inc
PPLI
+$1.63M
5
JNJ icon
Johnson & Johnson
JNJ
+$1.41M

Sector Composition

Rank Sector Weight
1 Healthcare 17.45%
2 Technology 17.44%
3 Financials 11.3%
4 Materials 10.73%
5 Communication Services 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
151
Coca-Cola
KO
$360B
$794K 0.05%
11,096
-290
-3% -$19.4K
MDLZ icon
152
Mondelez International
MDLZ
$77.8B
$793K 0.05%
11,692
-66
-0.6% -$4.07K
VTI icon
153
Vanguard Total Stock Market ETF
VTI
$654B
$792K 0.05%
2,882
– –
ETR icon
154
Entergy
ETR
$53.3B
$766K 0.05%
8,966
– –
CRM icon
155
Salesforce
CRM
$143B
$761K 0.05%
2,839
– –
CW icon
156
Curtiss-Wright
CW
$27.1B
$752K 0.05%
2,372
– –
RARE icon
157
Ultragenyx Pharmaceutical
RARE
$2.67B
$733K 0.05%
20,255
– –
IWR icon
158
iShares Russell Mid-Cap ETF
IWR
$56B
$709K 0.05%
8,344
– –
CET
159
Central Securities Corp
CET
$1.55B
$663K 0.04%
14,749
-1,292
-8% -$59.9K
WMT icon
160
Walmart Inc
WMT
$886B
$659K 0.04%
7,512
+12
+0.2% +$1.13K
MRVL icon
161
Marvell Technology
MRVL
$170B
$650K 0.04%
10,573
– –
TT icon
162
Trane Technologies
TT
$106B
$633K 0.04%
1,880
– –
NPWR icon
163
NET Power
NPWR
$126M
$620K 0.04%
235,930
-105,475
-31% -$744K
BAH icon
164
Booz Allen Hamilton
BAH
$8.68B
$615K 0.04%
5,890
– –
MTD icon
165
Mettler-Toledo International
MTD
$27B
$590K 0.04%
500
– –
IWF icon
166
iShares Russell 1000 Growth ETF
IWF
$120B
$583K 0.04%
6,468
-40
-0.6% -$3.95K
NBIX icon
167
Neurocrine Biosciences
NBIX
$17.7B
$553K 0.04%
5,000
– –
IQV icon
168
IQVIA
IQV
$35.3B
$528K 0.04%
3,000
– –
PNC icon
169
PNC Financial Services
PNC
$99.5B
$492K 0.03%
2,800
– –
MRSH
170
Marsh
MRSH
$87.9B
$488K 0.03%
2,000
– –
UTHR icon
171
United Therapeutics
UTHR
$26.5B
$441K 0.03%
+1,431
New +$490K
NXDR
172
Nextdoor Holdings
NXDR
$866M
$439K 0.03%
287,000
– –
SXI icon
173
Standex International
SXI
$3.68B
$433K 0.03%
2,685
– –
GEHC icon
174
GE HealthCare
GEHC
$28.2B
$429K 0.03%
5,323
-1
-0% -$86
RSG icon
175
Republic Services
RSG
$67.5B
$423K 0.03%
1,750
– –
5 6
7
8 9

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
PPW
Parcion Private Wealth Bellevue, Washington $1.61B AUM 31.08% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
RC
Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return
TLFA
True Link Financial Advisors San Francisco, California $1.62B AUM 8.33% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

S&CO Inc's Q1 2025 Portfolio in Review

As of Q1 2025, S&CO Inc held 221 positions worth $1.49B, up 1.1% from $1.47B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

S&CO Inc's Q1 2025 filing shows 11 new, 53 increased, 54 reduced and 4 closed positions. Its largest new stake was Vertex Pharmaceuticals: 4,103 shares worth $1.99M. The largest sale was Apple, an estimated $6.62M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • S&CO Inc's largest Q1 2025 buy was Vertex Pharmaceuticals: 4,103 shares worth $1.99M.
  • S&CO Inc added most to Eli Lilly in Q1 2025, an estimated $4.62M increase.
  • S&CO Inc's biggest Q1 2025 reduction was Apple, cutting an estimated $6.62M.
  • S&CO Inc fully exited West Pharmaceutical in Q1 2025, selling an estimated $851K.
  • S&CO Inc's ten largest holdings make up 38% of its $1.49B portfolio in Q1 2025.
  • S&CO Inc opened 11 new positions and closed 4 in Q1 2025.
  • S&CO Inc's portfolio value rose 1.1% quarter-over-quarter to $1.49B.

Based on S&CO Inc's 13F filing for Q1 2025, filed 8 May 2025.